CD4 and type 1 diabetes mellitus: Second, we compared CD4+ T-cell responses against unmodified full-length C-peptide (PI33-63) to responses against variants of C-peptide comprising glutamine (Q) to glutamic acid (E) substitutions in PBMC from individuals with recent onset T1D.